← Insider buys
SPRO

Spero Therapeutics, Inc. · Healthcare

Aquilo Capital Management, LLC sold $2.5M of Spero Therapeutics, Inc.

10% owner

Sold$2,452,948
$14.09Price
174,100Shares
−4%Stake

What SPRO did after the filing

Prices for SPRO after this filing aren't in yet.

Traded Wed, Nov 4. Filed Fri, Nov 6, 3:48 PM ET, during the session. Not investment advice.